The impact of the COVID-19 pandemic on cancer care

The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients continue to receive essential care while minimizing exposure to SA...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Nature cancer Ročník 1; číslo 6; s. 565 - 567
Hlavní autori: Richards, Mike, Anderson, Michael, Carter, Paul, Ebert, Benjamin L., Mossialos, Elias
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England Nature Publishing Group 01.06.2020
Predmet:
Cancer surgery
Cancer therapies
Chemotherapy
Clinical trials
COVID-19
COVID-19 diagnostic tests
Disease transmission
Elective surgery
Endoscopy
Gastroenterology
Hospitals
Infections
Medical screening
Oncology
Pandemics
Patients
Radiation therapy
Severe acute respiratory syndrome coronavirus 2
United Kingdom > UK
England
United States > US
Health services
Oncology
Health policy
ISSN:2662-1347, 2662-1347
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients continue to receive essential care while minimizing exposure to SARS-CoV-2 infection.
Bibliografia:SourceType-Scholarly Journals-1
ObjectType-Commentary-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:2662-1347
2662-1347
DOI:10.1038/s43018-020-0074-y